Page last updated: 2024-08-17

folic acid and Cardiotoxicity

folic acid has been researched along with Cardiotoxicity in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Huang, X; Li, N; Qiao, M; Song, L; Wang, F; Wang, T; Zhao, Y1
Brandt, MM; Cheng, C; Chrifi, I; de Boer, M; Duimel, H; Duncker, DJ; Fliegner, D; Janssens, S; Kararigas, G; Kietadisorn, R; Moens, AL; Octavia, Y; Swinnen, M; Verheyen, FK1
Eum, J; Hwang, BJ; Kee, Y; Ki, S; Kim, KN; Kwon, SH; Raslan, AA1
Dong, Y; Wu, Y; Xu, H; Zhang, C; Zhao, L1
Ahmad, S; Dubey, K; Fahim, M; Kohli, K; Panda, BP1

Other Studies

5 other study(ies) available for folic acid and Cardiotoxicity

ArticleYear
Folic acid alleviates lead acetate-mediated cardiotoxicity by down-regulating the expression levels of Nrf2, HO-1, GRP78, and CHOP proteins.
    Environmental science and pollution research international, 2022, Volume: 29, Issue:37

    Topics: Acetates; Animals; Cardiotoxicity; Endoplasmic Reticulum Chaperone BiP; Folic Acid; Glutathione Peroxidase; Heat-Shock Proteins; Lead; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase

2022
Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.
    Journal of cellular and molecular medicine, 2017, Volume: 21, Issue:12

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Folic Acid; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mitochondria; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Stroke Volume; Superoxide Dismutase; Superoxides; Survival Analysis

2017
3D light-sheet assay assessing novel valproate-associated cardiotoxicity and folic acid relief in zebrafish embryogenesis.
    Chemosphere, 2019, Volume: 227

    Topics: Animals; Biological Assay; Cardiotoxicity; Diagnostic Imaging; Embryo, Nonmammalian; Embryonic Development; Folic Acid; Heart Defects, Congenital; Intravital Microscopy; Myocytes, Cardiac; Valproic Acid; Zebrafish

2019
Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
    Pharmaceutical biology, 2016, Volume: 54, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Area Under Curve; Biological Availability; Cardiotoxicity; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Doxorubicin; Drug Carriers; Drug Monitoring; Female; Folic Acid; Half-Life; Heart Diseases; HeLa Cells; Humans; Injections, Intravenous; Metabolic Clearance Rate; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Polyesters; Risk Assessment; Tissue Distribution; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2016
Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model.
    Pharmaceutical biology, 2017, Volume: 55, Issue:1

    Topics: Animals; Cardiotoxicity; Celecoxib; Disease Models, Animal; Folic Acid; Heart Failure; Male; Random Allocation; Rats; Rats, Wistar

2017